Medical Diagnostic and Treatment Center
| Lituania | Turchia | Austria | |
| Tomoterapia | - | da $12,000 | da $30,000 |
| Terapia con protoni | - | da $70,000 | da $80,000 |
| Sistema robotico Da Vinci | - | da $9,500 | da $22,000 |
| Segmentectomia polmonare | - | da $10,152 | - |
| Resezione a cuneo | - | da $7,300 | - |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Tumore al polmone. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Tumore al polmone e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Tumore al polmone.
Top hospitals for lung cancer treatment in Lithuania include the National Cancer Institute and Vilnius University Hospital Santaros Klinikos. These centers provide specialized thoracic surgery, immunotherapy, and multidimensional oncology care. Facilities often hold European certifications and Joint Commission International accreditation to ensure high patient safety.
Bookimed Expert Insight: While public university hospitals handle the highest volume of complex lung surgeries, private centers like the Medical Diagnostic and Treatment Center in Vilnius are often preferred for initial diagnostics. Our data shows these private facilities serve a significant international population, with 1 in 10 patients traveling from abroad, primarily to bypass wait times for essential scans and second opinions.
Patient Consensus: Patients note that while major centers offer advanced immunotherapy and research trials, overcrowding can lead to delays in starting chemotherapy. Those seeking faster access often use private insurance for initial diagnostics before transitioning to specialized institutes for surgery.
Lithuania provides advanced lung cancer care including robotic-assisted VATS lobectomies and stereotactic body radiotherapy (SBRT). Treatment centers in Vilnius and Kaunas utilize genetic testing for EGFR and ALK biomarkers. This allows for precise application of targeted therapies and immunotherapy drugs like Pembrolizumab.
Bookimed Expert Insight: Diagnostics in Vilnius are exceptionally efficient for international patients. The Medical Diagnostic and Treatment Center serves 60,000 patients annually with JCI accreditation. Data show 10% of their patients travel from abroad. This high volume ensures rapid access to PET-CT and genetic testing. This speed is critical for starting targeted therapy without the typical two-month public wait times.
Patient Consensus: Patients emphasize getting genetic testing early to unlock EU-approved targeted drugs quickly. They recommend consulting English-speaking oncologists in Vilnius but suggest seeking second opinions in Riga for extra confidence.
Lung cancer screening is available in Lithuania for individuals at high risk. The primary method is a low-dose computer tomography (LDCT) scan. Professionals recommend this procedure for adults aged 50 to 80. Eligible candidates typically have a 20 pack-year smoking history.
Bookimed Expert Insight: Vilnius remains the primary hub for advanced diagnostics in Lithuania. The Medical Diagnostic and Treatment Center serves over 48,000 patients annually. It holds Joint Commission International (JCI) accreditation for safety. Patients often choose private centers here to bypass long public waiting lists. This speed is vital for early-stage detection through LDCT scans.
Patient Consensus: Patients note that public insurance coverage often requires a specific referral. Many choose to pay out-of-pocket for private scans to ensure faster access and peace of mind.
Lung cancer survival in Lithuania averages approximately 10% for the 5-year relative rate. Outcomes depend heavily on the stage of diagnosis. Localized cases show a 43% survival rate. National screening programs now target high-risk groups to improve these figures through earlier detection.
Bookimed Expert Insight: Private centers like the Medical Diagnostic and Treatment Center see 60,000 patients annually. This high volume often leads to faster diagnostic paths than the public sector. Patients seeking surgery should prioritize JCI-accredited facilities in Vilnius. These clinics maintain international quality standards that can influence early-stage surgical success.
Patient Consensus: Patients note that while local surgery and chemotherapy are affordable, advanced immunotherapy is often sought abroad. Many emphasize that smoking-related delays often push diagnosis into later, more difficult stages.
Waiting times for lung cancer treatment typically range from 15 to 56 days globally. In Lithuania, urgent oncology cases may start treatment within 14 days. Routine surgical procedures often require 25 to 78 days. Private facilities in Vilnius frequently reduce these diagnostic waiting periods to under 7 days.
Bookimed Expert Insight: High-volume centers like the Medical Diagnostic and Treatment Center in Vilnius leverage 53 specialized departments to expedite care. With 200 doctors on staff, these large facilities coordinate multidisciplinary teams faster than smaller regional clinics. Patients from Sweden and Norway often choose Lithuanian private centers specifically to bypass 4-week public system bottlenecks.
Patient Consensus: Patients note that pushing for an emergency referral from a GP is essential for faster public care. Many suggest using private diagnostics to save weeks of waiting before transferring back to specialized hospital departments.